Kun-Liang Guan, Ph.D., is a Distinguished Professor of Pharmacology, University of California San Diego. He received his BS from Hangzhou University and his PhD from Purdue University. Dr. Guan was a faculty at the University of Michigan (1992-2007). He received the MacArthur Fellowship (1998), the American Society of Biochemistry and Molecular Biology Young Investigator Award (1999), and the Distinguished Alumni Award (2006) from Purdue University, and AAAS Fellow (2011). Dr. Guan’s research interest is on cellular signaling and cancer biology, particularly on protein phosphorylation in cell growth regulation and tumorigenesis. He has worked on the mitogen activated protein kinase (MAPK), the mechanistic target of rapamycin (mTOR), and the Hippo pathway. He has published over 300 peer-reviewed papers and is a highly cited researcher in Molecular Biology and Genetics (Goggle Scholar H-index 150). Dr. Guan is a co-founder of OncoImmune Inc. and Vivace Therapeutics.

Complete List of Dr. Guan’s Published Work:
https://pubmed.ncbi.nlm.nih.gov/?term=Guan+kl